The bubba, down-home, corn-pone, "just plain folks" persona would be impressive if he had ever managed to pull Vivitrol sales out of the cellar compared to the robust growth of buprenorphine. If this man ever had an original idea it would be a news worthy event. He's a walking corporate cliche with a southern drawl.
You think the “robust growth” of buprenorphine has to do with sales leadership? Hahahaha. Winner for the worst take on cafe pharma history.
Trying to calm everyone down to make sure they stay before a sell off. The product looks more stable and attractive if tenured reps are currently in place. Better get your resume in line. Bye-bye Vivitrol reps.
So a company is going to purchase Vivitrol, then fire all of the people that have sold it in all the non traditional pharma platforms it’s used and have all the relationships, and then hire a sales force that hasn’t done either? Or they’re just going to buy the drug and put it on the shelf and not promote it?
Yes, This happens all the time. Wake up. Companies have their own reps and will buy a product and give it to their own salesforce. The writing is on the wall.
Well, company sales keep growing quarter over quarter, year over year and so do my bonus payouts. Not bad for an MAT that competes with one where a doc can charge extra cash on top of insurance. We’ve got issues at the top just like all of Alkermes. A LOT more could be done to help the brand. But if someone buys Alkermes, the Vivitrol reps...with the exception of a handful...won’t be the ones needing to worry.
